Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minggui Pan

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|July 26, 2018
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDACYu Pan, Fengchun Lu, Ping Xiong, et al.
Cancers|May 14, 2025
Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult PatientsLauren J Li, Nam Bui, Everett J Moding, et al.
Journal of Inflammation (London, England)|March 28, 2017
Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cellsYu Pan, Haizong Fang, Fengchun Lu, et al.
Developmental Cell|June 3, 2006
Calcineurin/NFAT signaling in osteoblasts regulates bone massMonte M Winslow, Minggui Pan, Michael Starbuck, et al.
The Permanente Journal|August 8, 2022
Pain as Initial Presenting Symptom Is Associated With Delay to Seeking Medical Attention, Higher Risk of Relapse, and Shorter Survival in Patients With Early-Stage Extremity or Trunk Synovial SarcomaTiffany Seto, Maqdooda Merchant, Lee Jae Morse, et al.
The American Surgeon|November 28, 2022
A Multicenter Virtual Multidisciplinary Sarcoma Case Conference Improves Outcome for a Rare Soft Tissue Sarcoma (Dermatofibrosarcoma Protuberans)Amber L Chang, Hyunjee V Kwak, Minggui Pan, et al.
Oncoimmunology|May 10, 2019
Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1Yu Pan, Qinglin Fei, Ping Xiong, et al.
Medical Sciences (Basel, Switzerland)|March 21, 2019
Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern CaliforniaTiffany Seto, Mee-Na Song, Maily Trieu, et al.
Journal of Oncology Practice|September 8, 2016
Understanding Teamwork in the Provision of Cancer Care: Highlighting the Role of TrustElizabeth H Lazzara, Joseph R Keebler, Soosi Day, et al.
Cancers|September 13, 2025
Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi StudyDavid Campbell, Scott Ramsey, David Veenstra, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Experimental & Clinical Cancer Research : CR|July 26, 2018
WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDACYu Pan, Fengchun Lu, Ping Xiong, et al.
Cancers|May 14, 2025
Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult PatientsLauren J Li, Nam Bui, Everett J Moding, et al.
Journal of Inflammation (London, England)|March 28, 2017
Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cellsYu Pan, Haizong Fang, Fengchun Lu, et al.
Developmental Cell|June 3, 2006
Calcineurin/NFAT signaling in osteoblasts regulates bone massMonte M Winslow, Minggui Pan, Michael Starbuck, et al.
The Permanente Journal|August 8, 2022
Pain as Initial Presenting Symptom Is Associated With Delay to Seeking Medical Attention, Higher Risk of Relapse, and Shorter Survival in Patients With Early-Stage Extremity or Trunk Synovial SarcomaTiffany Seto, Maqdooda Merchant, Lee Jae Morse, et al.
The American Surgeon|November 28, 2022
A Multicenter Virtual Multidisciplinary Sarcoma Case Conference Improves Outcome for a Rare Soft Tissue Sarcoma (Dermatofibrosarcoma Protuberans)Amber L Chang, Hyunjee V Kwak, Minggui Pan, et al.
Oncoimmunology|May 10, 2019
Synergistic inhibition of pancreatic cancer with anti-PD-L1 and c-Myc inhibitor JQ1Yu Pan, Qinglin Fei, Ping Xiong, et al.
Medical Sciences (Basel, Switzerland)|March 21, 2019
Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern CaliforniaTiffany Seto, Mee-Na Song, Maily Trieu, et al.
Journal of Oncology Practice|September 8, 2016
Understanding Teamwork in the Provision of Cancer Care: Highlighting the Role of TrustElizabeth H Lazzara, Joseph R Keebler, Soosi Day, et al.
Cancers|September 13, 2025
Diagnosis, Treatment, and Unmet Needs of Dedifferentiated Liposarcoma in the United States: A Multidisciplinary Delphi StudyDavid Campbell, Scott Ramsey, David Veenstra, et al.
Pageof 5